Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study

BACKGROUND: Insulin is the recommend therapeutic agent of choice for the management of Cystic Fibrosis Related Diabetes (CFRD), despite only sub-optimal reductions in glycemic control and increased morbidity and mortality reported by centers using this agent. The newer insulin sensitizing agents dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Onady, Gary M, Langdon, Leora J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513574/
https://www.ncbi.nlm.nih.gov/pubmed/16790062
http://dx.doi.org/10.1186/1472-6823-6-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513574/
https://www.ncbi.nlm.nih.gov/pubmed/16790062
http://dx.doi.org/10.1186/1472-6823-6-4

Ejemplares similares